Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/08/1992 | EP0465189A2 Recombinant DNA expression vectors and DNA compounds that encode deacetylcephalosporin C synthase activity |
01/08/1992 | EP0465132A2 DNA and its use |
01/08/1992 | EP0465047A2 Modified tryptophan promoters |
01/08/1992 | EP0465024A1 Control of microsporogenesis using externally inducible promoter sequences |
01/08/1992 | EP0465009A1 Antimicrobial peptides and plant disease resistance based thereon |
01/08/1992 | EP0465008A2 A monoclonal antibody recognizing human pancreatic prophospholipase A2 |
01/08/1992 | EP0464922A1 Production of active pseudomonas glumae lipase in homologous or heterologous hosts |
01/08/1992 | EP0464867A1 Fusion proteins of interleukin-alpha with hirudin |
01/08/1992 | EP0464832A2 Cloned N-methylhydantoinase |
01/08/1992 | EP0464638A2 Oligonucleotide analogues with terminal 3'-3' or 5'-5'-internucleotide linkages |
01/08/1992 | EP0464590A2 Inhibition of coloration of human serum albumin |
01/08/1992 | EP0464553A2 DNA clone encoding precursor of lectin-like substance from Periplaneta americana and cloning therefor |
01/08/1992 | EP0464533A1 Fusionproteins with parts of immunoglobulins, their production and use |
01/08/1992 | EP0464461A2 Stilbensynthase gene of grapevine |
01/08/1992 | EP0464287A1 Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide |
01/08/1992 | EP0464184A1 Process for enzymatically treating substrates |
01/08/1992 | EP0464175A1 Extracellular form of the human fibroblast growth factor receptor |
01/08/1992 | EP0464147A1 Matrix metalloproteinase inhibitor peptides |
01/08/1992 | EP0464137A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives |
01/08/1992 | EP0464123A1 Polynucleotide probe, method and kit for the identification and detection of gram-negative bacteria |
01/08/1992 | EP0464067A1 Solid phase diagnosis of medical conditions. |
01/08/1992 | EP0462184A4 Method of treating viral infections using lfa-1 |
01/07/1992 | WO1992001041A1 A cDNA ENCODING THE RAT D1 DOPAMINE RECEPTOR LINKED TO ADENYLYL CYCLASE ACTIVATION AND EXPRESSION PRODUCT |
01/07/1992 | WO1992001001A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
01/07/1992 | US5079352 Purified thermostable enzyme |
01/07/1992 | US5079351 Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization |
01/07/1992 | US5079343 AIDS diagnosis |
01/07/1992 | US5079229 Modified eglin proteins |
01/07/1992 | US5079166 Pseudomonas or host containing toluene monooxygenase genes from Pseudomonas |
01/07/1992 | US5079165 Vaccines to prevent cholera and typhoid fever |
01/07/1992 | US5079163 Recombinant ricin toxin fragments |
01/07/1992 | US5079159 Method for making tissue plasminogen activator |
01/07/1992 | US5079155 Bioaffinity chromatography |
01/07/1992 | US5079151 Myxococcus cells, nucleotides, membrane permeability |
01/07/1992 | US5079143 Screening, observing effect of drug on a target protein of a parasite |
01/07/1992 | US5078996 Genetic engineering, anticancer agents |
01/07/1992 | CA2086761A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
01/07/1992 | CA2086411A1 Cdna encoding the rat d1 dopamine receptor linked to adenylyl cyclase activation and expression product |
01/07/1992 | CA2046249A1 Production of active pseudomonas glumae lipase in homologous or heterologous hosts |
01/07/1992 | CA2045951A1 Recombinant dna expression vectors and dna compounds that encode deacetylcephalosporin c synthase activity |
01/07/1992 | CA1293940C Cdna clone for human tyrosinase |
01/07/1992 | CA1293938C Purification of synthetic oligomers |
01/07/1992 | CA1293937C Polynucleotide hybridization assays employing catalyzed luminescence |
01/07/1992 | CA1293927C Bonding-inducing composition containing enamel matrix |
01/03/1992 | WO1992000372A1 Recombinant pigeon pox virus vaccine |
01/03/1992 | CA2084064A1 Recombinant pigeon pox virus vaccine |
01/02/1992 | EP0463848A2 Non-A, non-B hepatitis virus particles |
01/02/1992 | EP0463712A2 Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections |
01/02/1992 | EP0463707A1 Production of polyketide antibiotics |
01/02/1992 | EP0463706A1 Cloning and expression of xylanase genes from fungal origin |
01/02/1992 | EP0463591A1 Method for determining DNA sequences |
01/02/1992 | EP0463571A2 Recombinant human osteocalcin |
01/02/1992 | EP0463570A1 Detection of HIV infection by bioluminescence |
01/02/1992 | EP0463508A1 Method for injecting substances into cells |
01/02/1992 | EP0463395A1 Detection of poor metabolizers of drugs |
01/02/1992 | EP0463144A1 Magnetically responsive fluorescent polymer particles and application thereof. |
01/02/1992 | EP0463115A1 Acetylated heterologous polypeptides. |
01/02/1992 | EP0463110A1 Monoclonal antibodies for metallic cations |
01/02/1992 | EP0463109A1 Recombinant alpha-galactosidase, a therapy for fabry disease |
01/02/1992 | EP0463081A1 Hormone response element compositions and assay |
01/02/1992 | EP0463080A1 Cd8-based pharmaceuticals |
01/02/1992 | EP0463073A1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA |
01/02/1992 | EP0463064A1 Neuronal nicotinic acetylcholine receptor compositions containing the beta4 subunit |
01/02/1992 | EP0463059A1 Allergenic proteins from ragweed and uses therefor |
01/02/1992 | EP0463056A1 External regulation of gene expression |
01/02/1992 | EP0463053A1 Production and use of anthelmintic agents and protective immunogens |
01/02/1992 | EP0463047A1 Introducing an exogenous gene into birds |
01/02/1992 | EP0463037A1 Human macrophage migration inhibitory factor |
01/02/1992 | EP0463036A1 Immobilized oligonucleotide probes and uses therefor. |
01/02/1992 | EP0463024A1 Dna construct and modified yeast |
01/02/1992 | EP0255823B1 Dna encoding adasp?113 bd and adlys?46 , asp?113 bd thaumatin i |
01/02/1992 | EP0196319B1 Retroviral polypeptides associated with human cellular transformation |
01/02/1992 | EP0183776B1 A process for isolating a substantially insoluble polypeptide using non-ionic detergents. |
01/02/1992 | EP0179152B1 Diagnostic system for the detection of cytomegalovirus |
01/02/1992 | DE4020181A1 Neue promotorregion Last promoter region |
01/01/1992 | CN2091865U Device for shooting corpuscle by impact |
01/01/1992 | CN1057482A Electricity transferring device for cell electric fusion |
12/31/1991 | WO1992000328A1 Non-a non-b sequences |
12/31/1991 | US5077399 Phosphinothricin-resistance gene |
12/31/1991 | US5077392 Process for activation of recombinant protein produced by prokaryotes |
12/31/1991 | US5077388 Purification of human interleukin-4 from a secreted escherichia coli mutant |
12/31/1991 | US5077214 Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells |
12/31/1991 | US5077213 Recombinant vaccinia virus |
12/31/1991 | US5077211 Purification and administration of dna repair enzymes |
12/31/1991 | US5077209 Dicarboxylic acid transport genes |
12/31/1991 | US5077196 Arabinonucleic acid segment-containing probes for DNA/RNA assays |
12/31/1991 | US5077195 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
12/31/1991 | US5077193 Diagnostic kits |
12/31/1991 | US5077044 Prevention bacillary dysentery |
12/31/1991 | CA2072092A1 Non-a non-b sequences |
12/30/1991 | WO1992000373A1 Melanin production by transformed microorganisms |
12/30/1991 | CA2045720A1 Method for determining dna sequences |
12/30/1991 | CA2044307A1 Method for injecting substances into cells |
12/29/1991 | WO1992000375A1 Sex determining gene |
12/29/1991 | CA2085102A1 Sex determining gene |
12/28/1991 | WO1992000099A1 Method of introducing a peptide into the cytosol |
12/28/1991 | CA2086342A1 Method of introducing a peptide into a cytosol |
12/28/1991 | CA2036287A1 Polynucleotide phosphorodithioate as therapeutic agents for retroviral infections |
12/27/1991 | WO1992000080A1 Method for treating leukemias |
12/27/1991 | EP0462892A1 Vitamin B12 producing E.coli strains and process for the preparation of vitamin B12 by culture of those strains |